Dr. Danuta Jarocha graduated from Jagiellonian University, Medical College with a degree
in Medical Analytics, followed by a Ph.D. in Medical Biology. Her graduate work
combined hematopoietic stem cell transplantation-related clinical work with academic
research. Dr. Jarocha’s post-doctoral work enabled multiple, human mesenchymal stem
cells based, successful, medical experiments and clinical trials in Poland.
In 2014, Dr. Jarocha came to the USA to Dr. Poncz’s lab at CHOP to explore the
possibilities of using induced pluripotent stem cells as a source to produce donorindependent platelets. Next two years she worked in a gene therapy group with Dr. Rivella.
She successfully combined advanced cell culture methodology with the newest molecular
techniques including digital PCR and deep sequencing to develop new assays to perform
ALS20 ß-globin clinical vector analysis including percentage of full transcript containing
lentiviral particles, viral transcriptome sequence identity and transducibility of CD34+
clonogenic progenitors. Her next step, CRO-based industry experience, built a deep
understanding of new assay validation processes.
In 2022, Dr. Jarocha joined the TSCL as Senior Research Investigator to support
molecular assay development and molecular group operation. Her high-impact findings
have been published in Blood, Blood Advances, Hematologica, Transfusion, Stem Cells
Translational Medicine, Cell Transplantation, and others.
